What’s News in Markets: Defense Stocks Rise, Beer Beats, Pharma Deal

10 Jan 2026 · 5 min · 5 chapters

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

WSJ What’s News - Episode Summary

Episode Title

What’s News in Markets: Defense Stocks Rise, Beer Beats, Pharma Deal Host: Francesca Fontana Date: Saturday, January 10th Podcast Description: A quick look at the biggest stock moves of the week and the news that drove them.

---

Key Topics Covered

  1. U.S. Actions in Venezuela
  2. Geopolitical Context:
  3. President Trump's actions aimed at reviving Venezuela’s oil industry.
  4. Plans reported by the Wall Street Journal for long-term U.S. dominance over Venezuela's energy sector.
  5. Market Response:
  6. Shares of American oil companies, notably Chevron, rose significantly:
  7. Chevron: Up 5.1% on Monday and gained 4% for the week.
  1. Stock Market Performance
  2. Major Indexes:
  3. Dow Jones: +2.3%
  4. S&P 500: +1.6%
  5. Nasdaq: +1.9%
  1. Defense Stocks Rally
  2. Government Spending:
  3. President Trump’s proposal for a $1.5 trillion defense budget.
  4. This proposal represents over $500 billion more than the Pentagon's expected budget for the fiscal year.
  5. Company Performance:
  6. Lockheed Martin:
  7. Announced plans to triple Patriot missile production after a seven-year deal with the Pentagon.
  8. Shares gained about 2% on Tuesday and saw a weekly increase of 9.2%.
  1. Constellation Brands
  2. Sales Performance:
  3. Reported lower beer sales and profits, particularly affecting Hispanic customer demographics.
  4. Cited broader economic trends (weak consumer sentiment, soft job market) and a downturn in physically-demanding jobs contributing to lower beer sales.
  5. Market Reaction:
  6. Despite poor results, performance was better than Wall Street expectations.
  7. Shares increased 5.3% on Thursday and added 4.1% for the week.
  1. Eli Lilly Pharma Deal
  2. Acquisition Overview:
  3. Eli Lilly agreed to purchase drug maker Ventix Biosciences for approximately $1 billion.
  4. The deal positions Lilly to compete in new treatment areas, particularly related to inflammatory response.
  5. Market Impact:
  6. Ventix shares soared 37% on the announcement date, with a staggering 64% jump over the week.

---

Conclusion This episode of “What’s News in Markets” provided insights into key stock movements influenced by geopolitical events, government spending proposals, corporate performance, and strategic acquisitions in the pharmaceutical sector. The host, Francesca Fontana, highlighted the interconnectedness of these developments and their implications for market dynamics.

Additional Resources

  • For further details on stock performance, refer to Francesca's column "The Score" in the Wall Street Journal's Exchange section.
  • Sign up for the WSJ's free Markets A.M. newsletter for daily market updates.

---

Production Credits:

  • Produced by Michael LaValle
  • Supervising Producers: Jana Herron, Melanie Roy

Next Episode: Tune in next Saturday for more market insights!

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Chapters

Tap a time to open that second in VO

Overview of the Week's Trading

0:32 to 0:44

A recap of the trading week and market dynamics.

“Hey listeners, it's Saturday, January 10th.”

Geopolitical Impact on Oil Stocks

0:44 to 1:39

Discussion on how geopolitical events affected oil stocks this week.

“The first full trading week of the new year is in the bag.”

Defense Stocks Rally

1:39 to 2:26

Analysis of the rally in defense stocks following Trump's budget talk.

“Let's stay in Washington for a moment here, as another sector was making moves on news coming from the Trump administration.”

Constellation Brands' Sales Struggles

2:26 to 3:25

Examination of Constellation Brands' recent sales performance and challenges.

“You may know the company better as the importer of Corona Beer.”

Eli Lilly's Strategic Acquisition

3:25 to 4:21

Details on Eli Lilly's acquisition of Ventix Biosciences and its implications.

“Eli Lilly said Wednesday that it agreed to pay around$1 billion for drug maker Ventix Biosciences, a deal that could help Lilly compete in a promising new treatment area.”
Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:00Der Insolvenzantrag ist gestellt. Und plötzlich läuft alles im Eiltempo. Für unsere Protagonistin beginnt jetzt die härteste Phase. In Folge 4 unserer Serie Endstation Insolvenz zeigen wir, warum Offenheit zur wichtigsten Währung wird. Weshalb ein Insolvenzverwalter kein Gegner ist. Und wie sich ein Betrieb stabilisiert oder geordnet abgewickelt wird. Im Podcastkanal Gute Geschäfte von Kreditreform. Überall, wo es Podcasts gibt. Hey listeners, it's Saturday, January 10th. I'm Francesca Fontana for The Wall Street Journal, and this is What's News in Markets, our look at the biggest stock moves of the week and the news that drove them.

0:43Let's get to it. The first full trading week of the new year is in the bag. And it certainly wasn't a boring one. Traders had plenty to digest in the way of geopolitical uncertainty, namely the ripple effects of U.S. action in Venezuela. During the week, President Trump promised to revive the country's oil industry. And the Wall Street Journal reported on plans by the White House to dominate Venezuela's energy industry for years. And we saw how shares of American oil majors responded. Like Chevron, whose shares ended up jumping 5.1 % Monday and gaining 4 % for the week. And before we get to some other individual movers, let's see how the major indexes did.

1:24All three notched gains for the week, with the Dow rising 2.3%, the S &P 500 gaining 1.6%, and the Nasdaq increasing about 1.9%. Let's stay in Washington for a moment here, as another sector was making moves on news coming from the Trump administration. Defense stocks. President Trump's call for a bigger defense budget sparked a rally in Lockheed Martin and other U.S. weapons makers. Trump called for a$1.5 trillion defense budget, more than$500 billion more than the Pentagon is expected to receive this fiscal year. And he wrote about it in a social media post late Wednesday. And earlier in the week, Lockheed Martin said it would more than triple Patriot missile production after reaching a seven-year deal with the Pentagon.

2:13Lockheed shares ended up gaining about 2 % Tuesday and notched a weekly gain of 9.2%.

2:25Next up, let's talk Constellation Brands. You may know the company better as the importer of Corona Beer. Dedicated listeners will recall that we've talked about this company's continued struggle with beer sales in recent quarters. And this latest quarter wasn't much different. Constellation reported lower sales and profit as customers, particularly Hispanic customers, continued to buy less beer. In addition to the macro trends we've been hearing about from companies, like weak consumer sentiment and a softening job market, Constellation also cited a downturn in, quote, 4 ,000-calorie jobs, a.k.a.

3:00physically demanding jobs in areas like construction or mining, that typically boost beer sales. So the results released after the market close on Wednesday weren't great, but they were better than Wall Street was expecting. Shares closed 5.3 % higher on Thursday, and on the week they added 4.1%.

3:24Finally, we have a big pharma deal to talk about. Eli Lilly said Wednesday that it agreed to pay around$1 billion for drug maker Ventix Biosciences, a deal that could help Lilly compete in a promising new treatment area. Usually, when we're talking about buzzy pharma news, it's all about weight loss drugs like Ozempic and the like, but not today. Not directly, at least. Fentix has been focused on developing drugs targeting inflammatory response, and if its experimental pills pan out, they would add to Lilly's portfolio of treatments for autoimmune conditions, as well as for obesity and other related disorders.

4:02Und es könnte helfen Lilly, gegen andere große Rivals, including Ozempik-Maker Novo Nordisk, die Analysts say haben sich in diesem Emerging-Categorien. Ventik shares soaring 37 % Wednesday, und auf die Woche jumped eine whopping 64%. Und jetzt, was news in Markets this week. You can read about more stocks that moved on the week's news in The Score, my column in the Wall Street Journal's Exchange section. Today's show is produced by Michael LaValle with supervising producers Jana Herron and Melanie Roy I'm Francesca Fontana Have a great weekend and see you next Saturday

From the publisher

How American oil companies are responding following U.S. action in Venezuela? And why were Constellation investors happy with lower beer sales? Plus, how can a big pharma deal help Eli Lilly compete in a new treatment area? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them.

Sign up for the WSJ's free Markets A.M. newsletter.

Learn more about your ad choices. Visit megaphone.fm/adchoices

More from WSJ What’s News

All 335 episodes
What’s News in Markets: Defense Stocks Rise, Beer Beats, Pharma DealWSJ What’s News · 5 min
Listen in VO